Physician

Frank Patrick Henchy, MD

According to 2025 Medicare claims, Frank Henchy, MD (NPI: 1972590164) practices dermatology in the Hammond, LA market, with the plurality of this provider's patient population coming from Tangipahoa, LA. This provider's primary affiliated billing organization is NORTH OAKS PHYSICIAN GROUP, LLC (NPI: 1427035211; TIN: 452419394) and primary practice location at 70403-1452.

Henchy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 3,280 HCPCS/CPT codes, and received $124,901 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,766 prescription claims across 515 beneficiaries totaling $451,333 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 2 records totaling $112. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $99,229 to $451,333. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$70K$141K2015 Medicare payment: $140,994 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $133,321 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $128,669 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $133,182 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $135,463 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $94,522 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,808 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $126,449 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $112,107 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $124,901 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0913,816$140,994
20169523,791$133,321
20177934,041$128,669
20187984,204$133,182
20197703,864$135,463
20205592,632$94,522
20216033,137$122,808
20226443,232$126,449
20235582,942$112,107
20245263,280$124,901

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$226K$451K2015 Drug cost: $99,229 (USD; Tot_Drug_Cst)2016 Drug cost: $85,573 (USD; Tot_Drug_Cst)2017 Drug cost: $57,507 (USD; Tot_Drug_Cst)2018 Drug cost: $96,647 (USD; Tot_Drug_Cst)2019 Drug cost: $100,206 (USD; Tot_Drug_Cst)2020 Drug cost: $50,505 (USD; Tot_Drug_Cst)2021 Drug cost: $86,713 (USD; Tot_Drug_Cst)2022 Drug cost: $148,876 (USD; Tot_Drug_Cst)2023 Drug cost: $329,488 (USD; Tot_Drug_Cst)2024 Drug cost: $451,333 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157732,226$99,229
20167332,173$85,573
20175121,543$57,507
20185691,650$96,647
20195921,803$100,206
20204901,476$50,505
20215251,666$86,713
20225121,788$148,876
20235111,758$329,488
20245151,766$451,333

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth161181$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more280387$58
17000Destruction of precancer skin growth, 1 growth220341$34
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more258380$34
17003Destruction of precancer skin growth, 2-14 growths1731,277$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab411,106$150,505
OtezlaApremilast12360$55,496
KetoconazoleKetoconazole3709,591$5,253
FluocinonideFluocinonide1082,995$3,758
FluorouracilFluorouracil501,256$3,703

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$112Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Frank Patrick Henchy, MD?

Tedicare shows public-source Medicare data for Frank Patrick Henchy, MD (NPI 1972590164), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frank Patrick Henchy, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Frank Patrick Henchy, MD?

Frank Patrick Henchy, MD is linked to NORTH OAKS PHYSICIAN GROUP, LLC (billing NPI 1427035211) in the available physician profile data.

Does Frank Patrick Henchy, MD have Open Payments data?

Frank Patrick Henchy, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.